Institutional Ownership
Inspiremd Inc
CUSIP 45779A846COMNSPRQ1 2026
13D / 13G Filings
35
Schedule 13D/13G on record
Beneficial Filers
16
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
35
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
35 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Orbimed Advisors LLC | 13G | 7.4% | 31.33T | SEC |
| 2 | Feb 11, 2026 | Rosalind Advisors, Inc. | 13G/A | 9.2% | 10.99M | SEC |
| 3 | Feb 2, 2026 | Aberdeen Group PLC | 13G/A | 7.5% | 3.17M | SEC |
| 4 | Nov 14, 2025 | Nantahala Capital Management, LLC | 13G/A | 10.0% | 4.26M | SEC |
| 5 | Nov 14, 2025 | Nantahala Capital Partners Limited Partnership | 13G/A | 5.7% | 2.42M | SEC |
| 6 | Nov 14, 2025 | Orbimed Advisors LLC | 13G/A | 4.1% | 2.13M | SEC |
| 7 | Nov 14, 2025 | Parkman Healthcare Partners LLC | 13G | 5.8% | — | SEC |
| 8 | Nov 14, 2025 | Marshall Wace, LLP | 13G/A | 10.0% | 28.10M | SEC |
| 9 | Nov 7, 2025 | Aberdeen Group PLC | 13G | 6.0% | 2.48M | SEC |
| 10 | Oct 29, 2025 | Craig Shore | 13D/A | 3.5% | — | SEC |
25 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Inspiremd Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rosalind Advisors, Inc. | 3.91M | $6.37M |
| 2 | Nantahala Capital Management, LLC | 3.38M | $5.50M |
| 3 | Aberdeen Group PLC | 3.17M | $5.17M |
| 4 | Orbimed Advisors LLC | 3.13M | $5.11M |
| 5 | Parkman Healthcare Partners LLC | 2.42M | $3.94M |
| 6 | Velan Capital Investment Management LP | 2.10M | $3.42M |
| 7 | Marshall Wace, LLP | 1.86M | $3.03M |
| 8 | Soleus Capital Management, L.P. | 1.05M | $1.70M |
| 9 | Pura Vida Investments, LLC | 450.5K | $734.3K |
| 10 | Affiance Financial, LLC | 250.4K | $408.1K |